HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metoda Dodič-Fikfak Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

1/2011Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Metoda Dodič-Fikfak Research Topics

Disease

3Malignant Mesothelioma
01/2015 - 01/2012
1Disease Progression
01/2015
1Neoplasms (Cancer)
01/2015
1Asbestosis
01/2011

Drug/Important Bio-Agent (IBA)

2GemcitabineFDA Link
10/2012 - 01/2012
1Cisplatin (Platino)FDA LinkGeneric
01/2015
1SurvivinIBA
01/2015
1EnzymesIBA
01/2015
1ImmunosorbentsIBA
01/2015
1Inhibitor of Apoptosis ProteinsIBA
01/2015
1PlatinumIBA
10/2012
1AsbestosIBA
01/2011
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2015
1Combination Drug Therapy (Combination Chemotherapy)
10/2012